139 results on '"Wraith, David C"'
Search Results
2. SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection
3. The Incidence of Immune Mediated Inflammatory Diseases Following COVID-19: a Matched Cohort Study in UK Primary Care
4. SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection
5. Symptoms and risk factors for long COVID in non-hospitalized adults
6. SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation
7. Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study)
8. Adaptive T cell tuning in immune regulation and immunotherapy of autoimmune diseases✰
9. In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens
10. Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strength
11. Induction of Tolerance to Therapeutic Proteins With Antigen-Processing Independent T Cell Epitopes: Controlling Immune Responses to Biologics
12. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
13. Preclinical models of arthritis for studying immunotherapy and immune tolerance
14. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection
15. Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases
16. Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva
17. SARS‐CoV‐2‐specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi‐System Syndrome
18. The Mechanism of Action of Antigen Processing Independent T Cell Epitopes Designed for Immunotherapy of Autoimmune Diseases
19. 2 Are mesenchymal stem cells immune privileged?
20. Antigen and Checkpoint Receptor Recalibration of T Cell Receptor Signal Strength
21. Peptide allergen‐specific immunotherapy for allergic airway diseases— State of the art
22. A LAT-Based Signaling Complex in the Immunological Synapse as Determined with Live Cell Imaging is Less Stable in T Cells with Regulatory Capability
23. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
24. Nr4a1 and Nr4a3 Reporter Mice Are Differentially Sensitive to T Cell Receptor Signal Strength and Duration
25. Autoantigens in rheumatoid arthritis and the potential for antigen-specific tolerising immunotherapy
26. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
27. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases
28. Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
29. Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome
30. Chromatin Priming Renders T Cell Tolerance-Associated Genes Sensitive to Activation below the Signaling Threshold for Immune Response Genes
31. SARS-CoV-2 seroconversion in health care workers
32. Differential Nr4a1 and Nr4a3 expression discriminates tonic from activated TCR signalling events in vivo
33. Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study
34. Immunotherapy With Apitopes Blocks the Immune Response to TSH Receptor in HLA-DR Transgenic Mice
35. Variant proteins stimulate more IgM+ GC B-cells revealing a mechanism of cross-reactive recognition by antibody memory
36. Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
37. Designing antigens for the prevention and treatment of autoimmune diseases
38. The Future of Immunotherapy: A 20-Year Perspective
39. Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
40. Author response: Variant proteins stimulate more IgM+ GC B-cells revealing a mechanism of cross-reactive recognition by antibody memory
41. IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation
42. A humanized HLA-DR4 mouse model for autoimmune myocarditis
43. Myeloid‐derived suppressor cells mediate tolerance induction in autoimmune disease
44. Protein kinase C theta is required for efficient induction of IL-10-secreting T cells
45. Tr1-Like T Cells – An Enigmatic Regulatory T Cell Lineage
46. CNS infection safety signal of RTS,S/AS01 and possible association with rabies vaccine
47. Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice
48. Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy
49. Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
50. Glycogen synthase kinase‐3 controls IL‐10 expression in CD4+ effector T‐cell subsets through epigenetic modification of the IL‐10 promoter
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.